Quantcast

Robert Bazell Reports on the Expiration of Lipitor’s Patent

December 2, 2011

Robert Bazell (NBC Nightly News) reports the patent for Pfizer’s most popular drug ever ends at the end of this month. Now lower cost generics similar to the cholesterol lowering drug Lipitor will start hitting the market.



comments powered by Disqus